TrumpRx Expands Discount Drug Access With 600 Generic Medications

U.S. President Donald Trump announced that TrumpRx.gov will now offer more than 600 generic prescription drugs, significantly expanding the administration’s effort to lower medication costs for Americans. The government-backed platform, originally launched in January with branded medicines only, will now include widely used generic drugs such as atorvastatin for cholesterol treatment and metformin for diabetes management.

Trump revealed the expansion during a White House event attended by billionaire entrepreneur Mark Cuban, whose Cost Plus Drugs online pharmacy is partnering in the initiative. According to the administration, the update increases the number of medicines available on TrumpRx by nearly seven times.

TrumpRx does not directly sell medications. Instead, the website connects consumers to pharmacy providers offering discounted prescription drug prices. The platform will integrate pricing information and savings options from Amazon Pharmacy, Cost Plus Drugs, GoodRx, and local pharmacies, helping users compare affordable medication prices in one place.

The White House stated that generic medicines will be listed separately from discounted high-cost branded drugs. However, controlled substances and medications subject to FDA risk evaluation and mitigation strategies (REMS) will not be available through the service.

The Trump administration said the expansion is part of its broader “most-favored-nation” pricing strategy, which aims to align U.S. prescription drug prices with those paid in other developed countries. Trump previously secured agreements with 17 major pharmaceutical companies, offering temporary tariff exemptions in exchange for lower drug pricing commitments.

Officials estimate the policy could generate more than $64 billion in federal and state savings over the next decade. Still, questions remain about how much consumers will personally save, especially since purchases made through TrumpRx are generally intended for uninsured buyers and may not count toward insurance deductibles.

According to the U.S. Food and Drug Administration, more than 90% of medications sold in the United States are generic drugs, making the TrumpRx expansion a major step toward broader access to affordable healthcare.